Biosig Technologies Inc (BSGM) Peer Comparison
$5.01
As on 10-Oct-2025 09:30EDT
Market cap
$215 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
36.6
Div. Yield
0 %
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
Market cap ($ Mln) |
215 | 244 |
Revenue ($ Mln) |
0 | 0 |
Net Profit ($ Mln) |
-26.20 | -17.91 |
Net Margin (%) |
-201,515.38 | -4,210.19 |
RoE (%) |
-- | -154.96 |
Price to Earnings |
-- | -- |
Price-To-Book |
36.58 | 27.98 |
Income Statement ($ Mln)
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Operating Revenue
|
0.01 | 0.43 |
|
Cost of Revenue
|
0.00 | 0.58 |
|
Gross Profit
|
-- | -0.43 |
|
Operating Expenses
|
27.50 | 14.32 |
|
Operating Profit (EBIT)
|
-27.48 | -14.47 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-26.18 | -17.91 |
|
Provision for Tax
|
0.00 | 0.00 |
|
Profit after Tax (Net Income)
|
-26.20 | -17.91 |
|
Minority Interest
|
-0.02 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Shareholder's Funds
|
-3.51 | 8.62 |
|
Minority Interest
|
-0.02 | 0.00 |
|
Non-Current Liabilities
|
0.00 | 0.15 |
|
Current Liabilities
|
113.20 | 6.23 |
|
Total Liabilities
|
0.84 | 17.77 |
Assets ($ Mln)
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Non-Current Assets
|
106.72 | 1.54 |
|
Current Assets
|
3.00 | 13.46 |
|
Total Assets
|
-- | 17.77 |
|
Total Debt*
|
0.00 | 0.30 |
|
Net Current Assets
|
-110.20 | 7.23 |
Cashflow ($ Mln)
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Cash From Operating Activities
|
-4.76 | -13.97 |
|
Cash Flow from Investing Activities
|
-- | -0.08 |
|
Cash from Financing Activities
|
4.71 | 16.12 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
ROCE (%)
|
529.74 | -113.56 |
|
ROE (%)
|
474.72 | -154.96 |
|
ROA (%)
|
-22.88 | -106.88 |
|
EBIT Margin (%)
|
-211,400.00 | -3,436.13 |
|
Net Margin (%)
|
-201,515.38 | -4,210.19 |
|
Cash Profit Margin (%)
|
-0.32 | -0.01 |
Growth Ratios
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Revenue Growth (%)
|
-65.79 | 16.57 |
|
EBIT Growth (%)
|
-26.79 | 1.73 |
|
Net Profit Growth (%)
|
-27.28 | -53.19 |
|
EPS Growth (%)
|
-- | -41.89 |
|
Book Value Growth (%)
|
-- | 8.75 |
Valuation Ratios
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Price / Earnings
|
-- | -4.73 |
|
Price / Book Value
|
-- | 5.32 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-- | -3.89 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.02 |
|
Current Ratio
|
0.03 | 2.16 |
|
Quick Ratio
|
0.03 | 2.11 |
|
Interest Coverage
|
-- | -- |
Operating Efficiency Ratios
| Biosig Technologies Inc (BSGM) | Monogram Orthopaedics Inc. (MGRM) | |
|---|---|---|
|
Debtors to sales (%)
|
0.00 | 22.80 |
|
Asset Turnover
|
0.00 | 0.03 |
|
Receivable days
|
607.23 | -- |
|
Inventory Days
|
-- | 122.32 |
|
Payable days
|
-- | 1,544.36 |
|
Cash Conversion Cycle
|
-- | -- |